256 related articles for article (PubMed ID: 26708754)
1. Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice.
Assi M; Derbré F; Lefeuvre-Orfila L; Rébillard A
Free Radic Biol Med; 2016 Feb; 91():204-14. PubMed ID: 26708754
[TBL] [Abstract][Full Text] [Related]
2. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
3. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia.
Khamoui AV; Park BS; Kim DH; Yeh MC; Oh SL; Elam ML; Jo E; Arjmandi BH; Salazar G; Grant SC; Contreras RJ; Lee WJ; Kim JS
Metabolism; 2016 May; 65(5):685-698. PubMed ID: 27085776
[TBL] [Abstract][Full Text] [Related]
4. Antioxidants and muscle atrophy in colon cancer: beneficial or deleterious effects?
Derbré F; Assi M; Lefeuvre-Orfila L; Vincent S; Chevalier M; Gueritat J; Salaun E; Rebillard A
Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S22. PubMed ID: 26461307
[TBL] [Abstract][Full Text] [Related]
5. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.
Aulino P; Berardi E; Cardillo VM; Rizzuto E; Perniconi B; Ramina C; Padula F; Spugnini EP; Baldi A; Faiola F; Adamo S; Coletti D
BMC Cancer; 2010 Jul; 10():363. PubMed ID: 20615237
[TBL] [Abstract][Full Text] [Related]
6. Aliskiren targets multiple systems to alleviate cancer cachexia.
Wang C; Guo D; Wang Q; You S; Qiao Z; Liu Y; Dai H; Tang H
Oncol Rep; 2016 Nov; 36(5):3014-3022. PubMed ID: 27667116
[TBL] [Abstract][Full Text] [Related]
7. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia.
Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R
Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111
[TBL] [Abstract][Full Text] [Related]
8. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
[TBL] [Abstract][Full Text] [Related]
9. Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice.
Bonetto A; Penna F; Minero VG; Reffo P; Bonelli G; Baccino FM; Costelli P
Curr Cancer Drug Targets; 2009 Aug; 9(5):608-16. PubMed ID: 19508174
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice.
Asp ML; Tian M; Wendel AA; Belury MA
Int J Cancer; 2010 Feb; 126(3):756-63. PubMed ID: 19634137
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.
Judge SM; Wu CL; Beharry AW; Roberts BM; Ferreira LF; Kandarian SC; Judge AR
BMC Cancer; 2014 Dec; 14():997. PubMed ID: 25539728
[TBL] [Abstract][Full Text] [Related]
12. Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade.
Lautaoja JH; Lalowski M; Nissinen TA; Hentilä J; Shi Y; Ritvos O; Cheng S; Hulmi JJ
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E852-E865. PubMed ID: 30860875
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice.
Peters SJ; van Helvoort A; Kegler D; Argilès JM; Luiking YC; Laviano A; van Bergenhenegouwen J; Deutz NE; Haagsman HP; Gorselink M; van Norren K
Oncol Rep; 2011 Jul; 26(1):247-54. PubMed ID: 21503587
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.
Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S
Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114
[TBL] [Abstract][Full Text] [Related]
15. MG132-mediated inhibition of the ubiquitin-proteasome pathway ameliorates cancer cachexia.
Zhang L; Tang H; Kou Y; Li R; Zheng Y; Wang Q; Zhou X; Jin L
J Cancer Res Clin Oncol; 2013 Jul; 139(7):1105-15. PubMed ID: 23535871
[TBL] [Abstract][Full Text] [Related]
16. Myostatin is a novel tumoral factor that induces cancer cachexia.
Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
[TBL] [Abstract][Full Text] [Related]
17. Chronic Alcohol Consumption Enhances Skeletal Muscle Wasting in Mice Bearing Cachectic Cancers: The Role of TNFα/Myostatin Axis.
Li Y; Zhang F; Modrak S; Little A; Zhang H
Alcohol Clin Exp Res; 2020 Jan; 44(1):66-77. PubMed ID: 31657476
[TBL] [Abstract][Full Text] [Related]
18. Compound Z526 alleviates chemotherapy-induced cachectic muscle loss by ameliorating oxidative stress-driven protein metabolic imbalance and apoptosis.
Gu X; Lu S; Fan M; Xu S; Lin G; Zhao Y; Zhao W; Liu X; Dong X; Zhang X
Eur J Pharmacol; 2024 Jul; 974():176538. PubMed ID: 38552940
[TBL] [Abstract][Full Text] [Related]
19. Paeoniflorin alleviated muscle atrophy in cancer cachexia through inhibiting TLR4/NF-κB signaling and activating AKT/mTOR signaling.
Zhu Z; Li C; Gu X; Wang X; Zhang G; Fan M; Zhao Y; Liu X; Zhang X
Toxicol Appl Pharmacol; 2024 Mar; 484():116846. PubMed ID: 38331105
[TBL] [Abstract][Full Text] [Related]
20. Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice.
Chen MC; Hsu WL; Hwang PA; Chen YL; Chou TC
Oncotarget; 2016 Aug; 7(32):51608-51618. PubMed ID: 27323407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
